This pipeline enables scalable, reliable vertebral labeling and morphometric extraction of the upper cervical SC for multicenter studies and supports biomarker development in neurodegenerative diseases.
G. M. Jarola, D. H. Shiraishi, I. Adanyeguh et al.· npj Digital Medicine· 0 citations
Routine testing for anti-IgLON5 or other neuronal antibodies in AP is not recommended, but careful clinical phenotyping is essential to uncover additional features that might suggest an underlying antibody-associated disease in selected patient cases.
J. Kerstens, E. Dopper, L. D. Kaat et al.· Neurology(R) neuroimmunology...· 0 citations
The clinimetric properties of the Patient-Reported Outcome Measure of Ataxia (PROM-Ataxia) have only been partially explored. This study aimed to investigate its convergent validity, responsiveness, and minimal clinically important difference (MCID), as well as its discriminative ability at the earliest disease stages...
K. Leeuwenberg, T. V. van Prooije, C. Reniers et al.· Journal of Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.